Latent Tüberküloz: Bağışıklık Yanıtı ve Reaktivasyon Mekanizmaları
Referanslar
Flynn JL, Chan J. Tuberculosis: latency and reactivation. Infect Immun. 2001;69(7):4195-201. doi: 10.1128/IAI.69.7.4195-4201.2001.
Gupta A, Kaul A, Tsolaki AG, Kishore U, Bhakta S. Mycobacterium tuberculosis: immune evasion, latency and reactivation. Immunobiology. 2012;217(3):363-74. doi: 10.1016/j.imbio.2011.07.008.
Niu H, Hu Y, Li Q, Da Y, Xin Z. Advances in understanding immune homeostasis in latent tuberculosis infection. Wiley Interdiscip Rev Mech Dis. 2024;16(3):e1643. doi: 10.1002/wsbm.1643.
Tufariello JM, Chan J, Flynn JL. Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection. Lancet Infect Dis. 2003;3(9):578-90. doi: 10.1016/S1473-3099(03)00741-2.
Bozzano F, Marras A, De Maria A. Immunology of tuberculosis. Mediterr J Hematol Infect Dis. 2014;6(1):e2014027. doi: 10.4084/MJHID.2014.027.
Foreman TW, Mehra S, LoBato DN, Malek A, Alvarez X, Golden NA, et al. CD4+ T-cell–independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection. Proc Natl Acad Sci U S A. 2016;113(38):E5636-44. doi: 10.1073/pnas.1611987113.
Dutta NK, Karakousis PC. Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev. 2014;78(3):343-71. doi: 10.1128/MMBR.00010-14.
Miranda-Hernandez S, et al. CD8+ T cells mediate vaccination-induced lymphatic containment of latent Mycobacterium tuberculosis infection following immunosuppression, while B cells are dispensable. bioRxiv (Preprint). 2025. doi: 10.1101/2025.01.23.634479.
Druszczyńska M, Kowalewicz-Kulbat M, Fol M, Rudnicka W. Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies. Pol J Microbiol. 2012;61(1):3-10. doi: 10.33073/pjm-2012-001.
Magombedze G, Dowdy S, Mulder NH. Latent tuberculosis: models, computational efforts and the pathogen's regulatory mechanisms during dormancy. Front Bioeng Biotechnol. 2013;1:4. doi: 10.3389/fbioe.2013.00004.
Kiazyk S, Ball TB. Latent tuberculosis infection: An overview. Can Commun Dis Rep. 2017;43(3-4):62-6. doi: 10.14745/ccdr.v43i34a01.
Sharan R, et al. Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a Mycobacterium tuberculosis/SIV coinfection model. J Clin Invest. 2022;132(11):e153090. doi: 10.1172/JCI153090.
Kudryavtsev IV, et al. The role of the immune response in developing tuberculosis infection: from latent infection to active tuberculosis. Front Tuberc. 2024;2:1438406. doi: 10.3389/ftubr.2024.1438406.
Ahmad S. Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection. Clin Dev Immunol. 2011;2011:814943. doi: 10.1155/2011/814943.
Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin Immunol. 2004;110(1):2-12. doi: 10.1016/S1521-6616(03)00210-9.
Robert J, et al. Reactivation of latent tuberculosis with TNF inhibitors: critical role of the beta 2 chain of the IL-12 receptor. Cell Mol Immunol. 2021;18(7):1644-7. doi: 10.1038/s41423-021-00694-9.
Rao M, Ippolito TJ, Manca D, Zhan J, Jacobs WR Jr, Kaplan G. Latent TB Infection (LTBI)–Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. Int J Infect Dis. 2019;80S:S58-61. doi: 10.1016/j.ijid.2019.02.035.
Salgame P, Geadas GS, Collins L, Jones-López V, Ellner CD. Latent tuberculosis infection–revisiting and revising concepts. Tuberculosis (Edinb). 2015;95(4):373-84. doi: 10.1016/j.tube.2015.04.003.
Cardona PJ. Revisiting the natural history of tuberculosis, the inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Arch Immunol Ther Exp (Warsz). 2010;58(1):7-14. doi: 10.1007/s00005-009-0062-5.
Delogu G, Sali M, Fadda G. The spectrum of tuberculosis infection: new perspectives in the era of biologics. J Rheumatol Suppl. 2014;91:11-6. doi: 10.3899/jrheum.140097.
Zhang Y. Persistent and dormant tubercle bacilli and latent tuberculosis. Front Biosci. 2004;9:1136-56. doi: 10.2741/1291.
Khabibullina NR, Kutuzova AA, Burmistrova AA. The Biological and Clinical Aspects of a Latent Tuberculosis Infection. Trop Med Infect Dis. 2022;7(3):48. doi: 10.3390/tropicalmed7030048.
Chaves AS, Rodrigues MM, D'Império Lima MR. Challenging Mycobacterium tuberculosis dormancy mechanisms and their immunodiagnostic potential. Braz J Infect Dis. 2015;19(6):636-42. doi: 10.1016/j.bjid.2015.08.004.
Kaufmann SHE, McMichael AJ, Annunziato HY. Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis. Nat Med. 2005;11(4 Suppl):S33-44. doi: 10.1038/nm1221.
Castillo-Chavez C, Feng Z. A distributed delay model for tuberculosis. Math Biosci Eng. 1996;4(2):177-96.
Petrenko TI, Baranova IA, Raznatovska OM. A modern view on the mechanism of occurrence and development of latent tuberculosis infection. Literature review. Tuberkuloz Legenevi Hvorobi VIL-infekcia. 2022;(3):60-8. doi: 10.30978/tb2022-3-60.
Subbian S, Tsenova L, O’Brien P, Yang G, Koo MS, Peixoto B, et al. Spontaneous latency in a rabbit model of pulmonary tuberculosis. Am J Pathol. 2012;181(5):1711-24. doi: 10.1016/j.ajpath.2012.07.019.
Yu Y, et al. Noncanonical differentiation of memory B cells drives latent tuberculosis infection reactivation upon tumor necrosis factor-alpha inhibitor therapy: an integrative transcriptomic study. Int J Rheum Dis. 2025;38(3):e70311. doi: 10.1111/1756-185X.70311.